切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2018, Vol. 06 ›› Issue (01) : 15 -18. doi: 10.3877/cma.j.issn.2095-5820.2018.01.005

所属专题: 文献

专题笔谈

脓毒症对患者生存健康的长期影响
宁永忠1,(), 赵敬焕1, 李祥1, 傅琪瑶1, 王俊文1   
  1. 1. 100022 北京,清华大学附属垂杨柳医院检验科
  • 收稿日期:2017-08-23 出版日期:2018-02-28
  • 通信作者: 宁永忠

Long-term effect of sepsis on the survival of the patients

Yongzhong Ning1,(), Jinhuan Zhao1, Xiang Li1, Qiyao Fu1, Junwen Wang1   

  1. 1. Department of Laboratory Medicine, Chuiyangliu Hospital affiliated to Tsinghua University, Beijing 100022, China
  • Received:2017-08-23 Published:2018-02-28
  • Corresponding author: Yongzhong Ning
  • About author:
    Corresponding author: Ning Yongzhong, Email:
引用本文:

宁永忠, 赵敬焕, 李祥, 傅琪瑶, 王俊文. 脓毒症对患者生存健康的长期影响[J/OL]. 中华临床实验室管理电子杂志, 2018, 06(01): 15-18.

Yongzhong Ning, Jinhuan Zhao, Xiang Li, Qiyao Fu, Junwen Wang. Long-term effect of sepsis on the survival of the patients[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2018, 06(01): 15-18.

脓毒症始于感染,通过感染导致宿主反应失调,引起多器官功能障碍,以至威胁生命。研究发现,脓毒症患者晚期病死率明显增加;由于再次感染而再次入院的几率也增加,且感染的病原有一定的特点。另外,脓毒症长期影响还可能导致患者不同程度的认知损伤,包括抑郁和谵忘;脓毒症还是引发心血管疾病的风险因素。及时抢救脓毒症患者可减少其短期器官功能障碍,减少病死率,以及减少患者生存健康的长期影响。

Sepsis leads to multi-organ dysfunction that threatens patients′life. It is caused by a deregulated host response to infection. It has been found that the late mortality of septic was significantly increased; the probability of rehospitalisation due to recurrent infection was also increased, and the infection pathogen of sepsishad certain characteristics. In addition, sepsis can cause cognitive impairment including depression and delirium. Sepsis is also the risk factor of subsequent cardiovascular diseases. Timely rescue to reduce short-term organ dysfunction can reduce mortality and reduce long-term effects of sepsis.

1
Prescott HC, Osterholzer JJ, Langa KM, et al. Late mortality after sepsis: propensity matched cohort study[J]. BMJ, 2016,353:i2375.
2
Agarwal A, Agarwal A. Infection associated secondary hemophagocytic lymphohistiocytosis in sepsis syndromes - A tip of an iceberg[J]. J Assoc Physicians India, 2016,64(10):44-50.
3
Shankar-Hari M, Rubenfeld GD. Understanding long-term outcomes following sepsis: Implications and challenges[J]. Curr Infect Dis Rep, 2016,18(11):37.
4
Shankar-Hari M, Ambler M, Mahalingasivam V, et al. Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies[J]. Crit Care, 2016,20:101.
5
Ou SM, Chu H, Chao PW, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study[J].Am J Respir Crit Care Med, 2016,194(2):209-217.
6
Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis[J]. Crit Care Med, 2014,42(3):625-631.
7
Krumholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia[J]. JAMA, 2013,309(6):587-593.
8
Borzecki AM, Chen Q, Restuccia J, et al. Do pneumonia readmissions flagged as potentially preventable by the 3M PPR software have more process of care problems? A cross-sectional observational study[J]. BMJ Qual Saf, 2015,24(12):753-763.
9
Prescott HC, Langa KM, Liu V, et al. Increased 1-year healthcare use in survivors of severe sepsis[J]. Am J Respir Crit Care Med, 2014,190(1):62-69.
10
Prescott HC, Langa KM, Iwashyna TJ, et al. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions[J]. JAMA, 2015,313(10):1055-1057.
11
Jones TK, Fuchs BD, Small DS, et al. Post-acute care use and hospital readmission after sepsis[J]. Ann Am Thorac Soc, 2015,12(6):904-913.
12
Sun A, Netzer G, Small DS, et al. Association between index hospitalization and hospital readmission in sepsis survivors[J]. Crit Care Med, 2016,44(3):478-487.
13
Wang T, Derhovanessian A, De Cruz S, et al. Subsequent infections in survivors of sepsis: epidemiology and outcomes[J]. J Intensive Care Med, 2014,29(2):87-95.
14
Zhao GJ, Li D, Zhao Q, et al. Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study[J]. Sci Rep, 2016,6:38361.
15
Walton AH, Muenzer JT, Rasche D, et al. Reactivation of multiple viruses in patients with sepsis[J]. PLoS One, 2014,9(2):e98819.
16
Lopez Roa P, Hill JA, Kirby KA, et al. Coreactivation of human herpesvirus 6 and cytomegalovirus is associated with worse clinical outcome in critically ill adults[J]. Crit Care Med, 2015,43(7):1415-1422.
17
Fromentin DM, Gauzit R, Gille B, et al. First description of herpes simplex virus type 1 epididymo-orchitis: A new clinical form of herpes simplex virus infection during septic shock[J]? IDCases, 2016,6:26-28.
18
Lachance P, Chen J, Featherstone R, et al. Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis[J]. Syst Rev, 2016,5(1):127.
19
Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate[J]. Crit Care, 2011,15(4):R183.
20
Guirgis FW, Brakenridge S, Sutchu S, et al. The long-term burden of severe sepsis and septic shock: sepsis recidivism and organ dysfunction[J]. J Trauma Acute Care Surg, 2016,81(3):525-532.
21
Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis[J]. JAMA, 2010,304(16):1787-1794.
22
Shah FA, Pike F, Alvarez K, et al. Bidirectional relationship between cognitive function and pneumonia[J]. Am J Respir Crit Care Med, 2013,188(5):586-592.
23
Davydow DS, Hough CL, Langa KM, et al. Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans[J]. Am J Geriatr Psychiatry, 2013,21(9):887-897.
24
Klein Klouwenberg PM, Zaal IJ, Spitoni C, et al. The attributable mortality of delirium in critically ill patients: prospective cohort study[J]. BMJ, 2014,349:g6652.
25
Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium[J]. J Intensive Care, 2016,4:18.
26
Yende S, Linde-Zwirble W, Mayr F, et al. Risk of cardiovascular events in survivors of severe sepsis[J]. Am J Respir Crit Care Med, 2014,189(9):1065-1074.
27
Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease[J]. JAMA, 2015,313(3):264-274.
28
Jafarzadeh SR, Thomas BS, Warren DK, et al. Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events[J]. Clin Infect Dis, 2016,63(4):495-500.
29
Dalager-Pedersen M, Søgaard M, Schønheyder HC, et al. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study[J]. Circulation, 2014,129(13):1387-1396.
30
Shih CJ, Chao PW, Ou SM, et al. Long-term risk of cardiovascular events in patients with chronic kidney disease who have survived sepsis: anationwide cohort study[J]. J Am Heart Assoc, 2017,6(2). pii: e004613.
31
Delano MJ, Ward PA. The immune system′s role in sepsis progression, resolution, and long-term outcome[J]. Immunol Rev, 2016,274(1):330-353.
32
Suzuki K, Inoue S, Kametani Y, et al. Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis[J]. Shock, 2016,46(3):270-278.
33
von Bahr V, Hultman J, Eksborg S, et al. Long-term survival in adults treated with extracorporeal membrane oxygenation for respiratory failure and sepsis[J]. Crit Care Med, 2017,45(2):164-170.
34
Linder A, Lee T, Fisher J, et al. Short-term organ dysfunction is associated with long-term (10-Yr) mortality of septic shock[J]. Crit Care Med, 2016,44(8):e728-736.
[1] 陈晓玲, 钟永洌, 刘巧梨, 李娜, 张志奇, 廖威明, 黄桂武. 超高龄髋膝关节术后谵妄及心血管并发症风险预测[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 575-584.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[4] 张霞, 张瑞, 郑志波, 张勤. 紫草素调控乳酸化修饰和线粒体功能改善脓毒症心肌病小鼠的预后[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 275-284.
[5] 张婧琦, 江洋, 孙佳璐, 唐兴喆, 赵宇飞, 崔颖, 李信响, 戴景月, 傅琳, 彭新桂. 基于肾周CT特征结合血清肌酐水平探讨脓毒症伴急性肾损伤的早期识别[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 285-292.
[6] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[7] 樊恒, 孙敏, 朱建华. 红景天苷通过抑制PI3K/AKT/mTOR信号通路对大鼠脓毒症急性肾损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 188-195.
[8] 寇宛婷, 蔡英华, 周海琴, 吴琼. 肺移植术后谵妄影响因素的范围综述[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 251-256.
[9] 袁延丽, 屈卓军, 崔会慧, 王菁, 高贝贝, 潘院. 原发性肺癌切除术后谵妄的危险因素及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 701-706.
[10] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[11] 陈曦, 吴宗盛, 郑明珠, 邱海波. 胸腺萎缩在脓毒症免疫紊乱中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 379-383.
[12] 杨翔, 郭兰骐, 谢剑锋, 邱海波. 转录组学在脓毒症诊疗中的临床研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 384-388.
[13] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[14] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
[15] 席静妮, 李娜, 张琪. 中性粒细胞与淋巴细胞比值对老年重症社区获得性肺炎进展为脓毒症的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 28-31.
阅读次数
全文


摘要